IBB News 255.45 07/25/2014 05:17:21 Nasdaq Biotechnology Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Biotechnology Ishares (IBB) 255.45 $IBB

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.12% Rise
Comtex SmarTrend(R) - Tue Jul 22, 4:11PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $252.27 to a high of $254.88. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $251.52 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Are Biotechs Overvalued?
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Mon Jul 21, 9:23AM CDT
U.S stocks are marginally lower on Monday morning, with the benchmark S&P 500 and the narrower Dow Jones Industrial Average down 0.38% and 0.48%, respectively, at 10:18 a.m. EDT. This week is relatively light in terms of economics data, but...

The Fed's Valuation Concerns Put These Growth ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 17, 9:00AM CDT
Thanks to Yellen and her comments, these high growth ETFs could be in focus.

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 1.43%
Comtex SmarTrend(R) - Wed Jul 16, 4:30PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $248.20 to a high of $253.42. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $250.89 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market
at The Street - Wed Jul 16, 10:40AM CDT
Recent comments by Fed Chair Janet Yellen and activist investor Carl Icahn have led to selling pressure in small-cap stocks.

Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation
at The Street - Tue Jul 15, 3:19PM CDT
Major indices trembled and the Nasdaq slid Tuesday following Fed Chair Janet Yellen's remarks on biotech and social media valuations.

Fed: These Two Industries Look Overvalued - Real Time Insight
Todd Bunton - Zacks Investment Research - Tue Jul 15, 1:29PM CDT
In a recent report to Congress, the Fed highlighted "stretched" valuations in two specific industries.

Fed Chair Yellen Says Small Biotech Stocks Over-Valued
at The Street - Tue Jul 15, 12:10PM CDT
Biotech indices plunge on cautious remarks made by Fed Chairwoman during Congressional testimony.

Stock Market Today: Biotech, Social Media Stocks Slide Following Yellen's Remarks
at The Street - Tue Jul 15, 11:14AM CDT
Major U.S. stock markets slide Tuesday following Fed Chair Janet Yellen's remarks on biotech and social media valuations.

Earnings Preview: Abbott Laboratories and Johnson & Johnson
George Budwell, The Motley Fool - Motley Fool - Mon Jul 14, 1:30PM CDT
The health care sector in general, and biotech industry in particular, have now shrugged off their earlier first quarter dip. For instance, the iShares Nasdaq Biotech Index has rallied a little over 13% year to date, although this closely watched...

'Fast Money' Recap: Confusion in the Market
at The Street - Fri Jul 11, 4:00AM CDT
The trading panel discussed whether investors are too complacent and whether it's a good idea to buy Microsoft again.

'Fast Money' Recap: Digging Into Oil Prices
at The Street - Thu Jul 10, 4:00AM CDT
The trading panel looked at whether WTI will go lower, how that will affect transportation stocks and how successful a Kim Kardashian mobile game app can be.

iShares Nasdaq Biotechnology Index Falls 2.14% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jul 08, 4:32PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $251.76 to a high of $258.50. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $258.83 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 2.14% Loss
Comtex SmarTrend(R) - Tue Jul 08, 4:31PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $251.76 to a high of $258.50. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $258.83 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Today's 3 Most Volatile Biotech Stocks
Todd Campbell, The Motley Fool - Motley Fool - Tue Jul 08, 4:05PM CDT
Biotechnology stocks are never short on volatility and today was no different as markets turned lower and biotech stocks were particularly hard hit. The  Nasdaq Biotechnology Index ETF dropped more than 2% as investors embraced safety and avoided...

Do Illumina and Incyte Belong in Your Portfolio?
Selena Maranjian, The Motley Fool - Motley Fool - Mon Jul 07, 5:15PM CDT
Source: Konrad Forstner, Wikimedia Commons. Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some biotech companies to your portfolio but don't have the time or expertise to...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Older Adults Embrace Cosmetic Dentistry for Confidence

Updated Category News Views 161

Why the Shift to Cosmetic Dentistry Later in Life? Aging doesn't just wrinkle your skin; it affects your smile too. Dr. Joseph T. Sumrall and Dr. Gran Sumrall, the dental gurus of Warner Robins, Georgia, are laying out why more adults are jumping on the cosmetic dentistry bandwagon as they age. Spoiler: It ain't about getting a movie-star grin but something much deeper....

Continue Reading
Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 127

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 58

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 118

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 147

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 89

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading
Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 142

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 222

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
Nord Anglia Schools Shine with 13 Tes Awards Nominations

Updated Category News Views 154

Nord Anglia's Moment of Glory at Tes Awards You think you know the big players in the educational game? Well, guess again. Nord Anglia's come out swinging with a whopping 13 finalist nominations at the 2026 Tes Awards for International Schools. It ain't easy making waves in the education sector, but these folks are showing they've got what it takes to turn heads, not just...

Continue Reading
Trades Workforce Shortage Costs Wallop U.S. Economy

Updated Category News Views 113

The Forgotten Backbone of America Don't sleep on this: America's got itself a trade worker crisis, and it's not just a numerical hiccup. We’re down nearly 1.9 million skilled trades workers, and that's a gut punch to the economy—a hefty $1.2 billion a day in GDP loss. These are the folks who keep the wheels greased, the lights on, and the goods flowing. Without them,...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Insights: S&P 500 Forecasted Decline and Job Growth Impact

Updated Category News Views 107

Market Insights on Economic Factors Impacting S&P 500 Recent reports have revealed that the job market in the United States is displaying significant strength. According to recent statistics, there was an addition of 256,000 jobs, which paints a picture of a robust economy. However, this strong job growth can bring mixed signals for investors regarding the stock market,...

Continue Reading
Safety Tech in Fleets: Drivers Embrace Its Role

Updated Category News Views 65

Drivers Warming Up to Fleet Safety Tech Seems like most fleet drivers these days are eyeing safety tech through a fresher lens. Gone are the days when grumbling about privacy was the anthem of the disgruntled. The latest Linxup survey claims a whopping 77% of commercial fleet pros have hopped onto the safety train, happily trading privacy qualms for the perks of solid...

Continue Reading
Celebrating 50 Years of Excellence at Amerijet Airlines

Updated Category News Views 200

Amerijet International Airlines: A Milestone Celebration Amerijet International Airlines proudly celebrates its 50th anniversary this year, marking five decades of dedication to air cargo services that connect diverse regions. Founded by David Bassett in 1974, the airline began its journey as a small Part 135 air-taxi operator, operating a single leased aircraft. Over the...

Continue Reading
Petit Pot Wins $100K Prize at 2024 Real California Milk Event

Updated Category News Views 195

Petit Pot Celebrates a Momentous Achievement in Dairy Innovation In an exciting showcase of dairy innovation, Petit Pot has emerged as the grand prize winner of the 2024 Real California Milk (RCM) Excelerator competition. This prestigious award highlights the company's commitment to producing high-quality dairy-based desserts and its remarkable sales achievements in a...

Continue Reading
Exploring the Affordability and Safety Debate in Autos

Updated Category News Views 295

Affordability Angst, and a Scapegoat Nobody Asked For Echoes of old policy fights come roaring back here—every time car prices spike, somebody points at safety rules like they’re the boogeyman under the bed (and, yeah, it kinda ticks me off). Lawmakers have been poking at features like Auto Emergency Braking, and the broader affordability debate has gotten tangled up...

Continue Reading